The Lewis acid catalyzed asymmetric synthesis of bamino-cyclohexyl sulfonates via aza-Michael addition is reported.As key step the addition of (S)-1-amino-2-methoxymethyl-pyrrolidine (SAMP) or (R,R,R)-2-amino-3-methoxymethyl-2-azabicyclo[3.3.0]-octane (RAMBO) to alkenyl-cyclohexyl sulfonates is applied, to give b-hydrazino sulfonates in moderate to good yields and diastereomeric excesses (yield = 41-85%, de = 55-90%). The epimers are separated by preparative HPLC, followed by reductive N-N bond cleavage with BH 3 ×THF and protection of the resulting amines with CbzCl to afford NCbz-protected-b-amino-cyclohexyl sulfonates in moderate to good yields (38-68%, 2 steps) and enantiomeric excesses (ee) of ³96%.The synthesis of unnatural amino acids is still of great importance, since these compounds can be utilized for example in the preparation of new peptides with a high potential for biological activities. In recent years 2-substituted taurines were used in the synthesis of b-amino sulfonopeptides. 1 White et al. designed b-sulfonopeptides as inhibitors of D-alanyl-D-alanine transpeptidases containing a taurine instead of a penultimate amino acid. 2 Furthermore, Liskamp et al. synthesized oligopeptido sulfonamides on solid phase in order to analyze their three-dimensional structure and biological activity. 3In addition to the peptides, the b-amino-sulfonates themselves are of great interest. The best known b-amino-sulfonic acid is taurine, but there are also other interesting derivatives like 2-amino-2-phenylethanesulfonic acid 4 as a potential GABA B receptor antagonist or flavocristamide 5 A and B, which have inhibitory activity against DNA polymerase a.The Michael reaction can provide an efficient access to the desired taurine derivatives. The first published azaMichael addition to alkenyl-sulfonates is dated to 1970, when Dumaitre et al. reacted primary and secondary amines with ethene-sulfonates. 6 During the following years, considerable attention towards the aza-Michael addition to alkenyl-sulfonates 7 has been shown, but to our knowledge enantioselective 1,4-additions with enantiopure nitrogen-nucleophiles have not been described.Scheme Reagents and conditions: a) ZnBr 2 (0.2 equiv), MeOH, add 3, add (S)-1 or (R,R,R)-2 (3.0 equiv), r.t., 7-14 d. b) BH 3 ×THF (10 equiv, 1.0 M in THF), THF, reflux, 5 h; r.t., add MeOH, reflux, 1 h. c) CbzCl (3.0 equiv), Na 2 CO 3 (6.0 equiv), CH 2 Cl 2 -H 2 O (4:1), reflux, 1-3 d.
A s y m m e t r i c S y n t h e s i s o f S u l f o n a t e s , b-Sultams a n d g-Sult o n e s Abstract: An efficient asymmetric synthesis of b-aminocyclohexyl sulfonates, b-sultams and g-sultones has been developed. The key step of the synthesis is the Lewis acid catalyzed aza-Michael addition of the enantiopure hydrazines SAMP [(S)-1] or RAMBO [(R,R,R)-2] to alkenylcyclohexyl sulfonates 3. This leads to b-hydrazino sulfonates 4a-k in moderate to good yields (41-85%) and diastereomeric excesses (de = 44-90%). The epimers were separated by preparative HPLC. Subsequent reductive N-N bond cleavage with BH 3 ·THF and protection of the resulting amines with CbzCl gave N-Cbz-protected b-aminocyclohexyl sulfonates 6a-k in moderate to good yields (38-68% over 2 steps) and high enantiomeric excesses (ee ³ 96%). a-Alkylation of 6 with various electrophiles afforded a-alkyl-b-aminocyclohexyl sulfonates 10a-g in good to excellent yields (67-92%) and moderate to high diastereomeric excesses (de = 71-93%). After alkylation with allyl iodide, the first asymmetric iodosultonization was achieved with high selectivities. Compounds 6g-k were also cyclized in a four-step synthesis to highly enantio-enriched 3-substituted-1,2-thiazetidine 1,1-dioxides (b-sultams) 9a-e.There is constant need for the synthesis of unnatural amino acids, since these compounds can provide new biological activities and their peptides are attractive targets for drug discovery. The best-known b-aminosulfonic acid is taurine, which is important for the evolution of the central nervous system of many mammals. Moreover, derivatives like 2-amino-2-phenylethanesulfonic acid, 1 a potential GABA B receptor antagonist or flavocristamides A and B, 2 which have inhibitory activity against DNA polymerase a, demonstrate the demanding interest for the asymmetric synthesis of taurine derivatives. Furthermore, the exchange of a-or b-amino acids in peptides for b-aminosulfonic acids or the synthesis of b-sulfonopeptides have drawn great attention. 3 White et al. designed b-sulfonopeptides as inhibitors of D-alanyl-Dalanine transpeptidase containing taurine instead of a penultimate amino acid. 4 Liskamp et al. synthesized oligo-petido sulfonamides on solid-phase starting from a-amino acids in order to analyze their secondary and tertiary structure as well as their biological activity. 5As we have described in a previous communication, the aza-Michael addition provides an efficient access to taurine derivatives. 6 As shown in Scheme 1, the reaction starts with 1,4-addition of enantiopure nitrogen nucleophiles to alkenyl sulfonates, followed by cleavage of the chiral auxilaries. This leads to chiral b-amino sulfonates, which can be used in the synthesis of 3-substituted 1,2-thiazetidine 1,1-dioxides (b-sultams) and g-sultones.Scheme 1 Asymmetric synthesis of b-aminocyclohexyl sulfonates, g-sultones and b-sultams by aza-Michael addition b-Sultams are the sulfonyl analogues of b-lactams. Therefore, they are interesting building blocks for the synthesis of new antibiotics, corre...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.